Table 2.
EQ-5Dindex score | N (Total 132) | Observed change |
P a | |
---|---|---|---|---|
Mean (SD) | SRM (95% CI) | |||
Clearly improvedb | 61 | 12.1 (13.9) | 0.87 (0.62-1.12) | <.001 |
Marginally improvedc | 50 | 5.9 (16.2) | 0.36 (0.08-0.64) | <.05 |
Marginally deterioratedd | 13 | 3.1 (12.5) | 0.25 (−0.29-0.79) | NS |
Clearly deterioratede | 8 | −8.7 (24.7) | −0.35 (−1.04-0.34) | NS |
Note. Change scores in the PRWE-Swe between the 3- and 12-month follow-ups were used as an external criterion (EC). EQ-5D = EuroQol Group 5-Dimension; SRM = standardized response mean; CI = confidence interval; NS = not significant; PRWE = Patient-Rated Wrist Evaluation.
Paired samples 2-sided t test.
Improvement in PRWE-Swe ≥ 10 points.
Improvement in PRWE-Swe < 10 points.
Deterioration in PRWE-Swe < 10 points.
Deterioration in PRWE-Swe ≥ 10 points.